2026-06-14T05:08:15Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/78312024-11-29T14:24:26Zcom_20.500.12105_2173com_20.500.12105_2051col_20.500.12105_19597

00925njm 22002777a 4500 dc Nikolić, Marko Z author Garrido-Martin, EM author Greiffo, Flavia R author Fabre, Aurélie author Heijink, Irene H author Boots, Agnes author Greene, Catherine M author Hiemstra, Pieter S author Bartel, Sabine author 2019-04 The European Respiratory Society (ERS) International Congress is the largest respiratory congress and brings together leading experts in all fields of respiratory medicine and research. ERS Assembly 3 shapes the basic and translational science aspects of this congress, aiming to combine cutting-edge novel developments in basic research with novel clinical findings. In this article, we summarise a selection of the scientific highlights from the perspective of the three groups within Assembly 3. In particular, we discuss new insights into the pathophysiology of the human alveolus, novel tools in organoid development and (epi)genome editing, as well as insights from the presented abstracts on novel therapeutic targets being identified for idiopathic pulmonary fibrosis. ERJ Open Res. 2019;5(2). pii: 00194-2018 10.1183/23120541.00194-2018 2312-0541 ERJ open research 31111040 http://hdl.handle.net/20.500.12105/7831 From the pathophysiology of the human lung alveolus to epigenetic editing: Congress 2018 highlights from ERS Assembly 3 "Basic and Translational Science."